COMPREHENSIVE EPITOPE ANALYSIS OF MONOCLONAL ANTI-PROENKEPHALIN ANTIBODIES USING PHAGE DISPLAY LIBRARIES AND SYNTHETIC PEPTIDES - REVELATION OF ANTIBODY FINE SPECIFICITIES CAUSED BY SOMATIC MUTATIONS IN THE VARIABLE REGION GENES
V. Bottger et al., COMPREHENSIVE EPITOPE ANALYSIS OF MONOCLONAL ANTI-PROENKEPHALIN ANTIBODIES USING PHAGE DISPLAY LIBRARIES AND SYNTHETIC PEPTIDES - REVELATION OF ANTIBODY FINE SPECIFICITIES CAUSED BY SOMATIC MUTATIONS IN THE VARIABLE REGION GENES, Journal of Molecular Biology, 247(5), 1995, pp. 932-946
Filamentous phage libraries, displaying 6, 12 or 20 amino acid residue
peptides at the N terminus of coat protein pill were used to define a
nd localize the epitopes of 15 monoclonal antibodies raised against hu
man proenkephalin, a neuropeptide precursor. Eight monoclonal antibodi
es (PE14 to PE19, PE23 and PE25), which inhibit each other's binding t
o proenkephalin, recognized phage clones selected by PE14, PE15, PE19,
PE23 and PE25. With the peptide sequences DLL(X)(X)LL (12mer library)
and DLL(X)(X)L (6mer library) shared by most of the phage clones it w
as possible to define the putative antibody epitope 155DLLKELL161 on h
uman proenkephalin. For five antibodies (PE13, PE20 to PE22 and PE24)
belonging to another inhibition group, a common consensus motif G(X)D(
X)E(X)(X)V(X)(X)R could be defined with the help of a 20mer library Th
e corresponding minimum epitope sequence has been found to be 175GSDNE
EEVSKR185. Antibody PE1, raised in a separate fusion, was able to sele
ct phage clones from a 12mer and 20mer library, revealing that the seq
uence 187GGFMRG192 is probably the antibody epitope. The assumed local
ization of the epitopes was confirmed by screening a set of overlappin
g synthetic peptides, covering the region of human proenkephalin thoug
ht to contain all antibody binding sites. It was found that antibodies
, although recognizing the same epitope, gave different binding patter
ns with the selected phage clones. By analysing the V-H chain sequence
s of these antibodies it could be shown that a varying number of somat
ic mutations is likely to be the reason for the observed differences i
n antibody fine specificity.